Latest News

Billionaire Li Ka-shing's Hutchmed in $608 mln health system stake sales

Hutchmed (China), controlled by magnate Li Kashing, is selling stakes in its health subsidiary for around $608 million as the billionaire and his flagship conglomerate aim to increase capital and pivot towards core operations at the drugmaker.

Hutchmed will offer a total 45% stake in Shanghai Hutchison Pharmaceuticals to Chinese firms GP Health Service Capital and Shanghai Pharmaceuticals, a stock exchange filing revealed on Wednesday.

Hutchmed's biggest shareholder is Hong Kong-listed corporation CK Hutchison, in which the billionaire investor has a 28.1% stake.

The biopharmaceutical business has had problem with problems pertaining to debt and high onshore liability levels in the recent past and the possible offer would even more assist the firm optimize capital and financial obligation structure, it stated.

The billionaire household's flagship companies, which has interests in real estate, selling and utilities around the globe, likewise reported a dip in profits throughout August, reflecting the increase of trade and geopolitical tensions.

Hutchmed prepares for to report a revenue of $477 million before income tax from the transaction, while the amount would be re-fed into the firm for advancement of core operations.

(source: Reuters)